Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods.

[1]  R. Pastorelli,et al.  Effect of dna repair gene polymorphisms on BPDE‐DNA adducts in human lymphocytes , 2002, International journal of cancer.

[2]  S. Hecht,et al.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. , 2002, Carcinogenesis.

[3]  H. Bartsch,et al.  Myeloperoxidase--463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients. , 2001, Carcinogenesis.

[4]  S R Tannenbaum,et al.  Gender- and smoking-related bladder cancer risk. , 2001, Journal of the National Cancer Institute.

[5]  M. Gross,et al.  Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke. , 2001, Chemical research in toxicology.

[6]  M. Borgerding,et al.  A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  S. London,et al.  Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  G. Scherer,et al.  Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  R. Santella,et al.  Carcinogen macromolecular adducts and their measurement. , 2000, Carcinogenesis.

[10]  Cheng-Huang Lin,et al.  On‐line identification of depurinating DNA adducts in human urine by capillary electrophoresis — fluorescence line narrowing spectroscopy , 2000, Electrophoresis.

[11]  E. Negri,et al.  Benzo(a)pyrene diolepoxide-haemoglobin and albumin adducts at low levels of benzo(a)pyrene exposure , 2000, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[12]  A Kopp-Schneider,et al.  Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. , 2000, Carcinogenesis.

[13]  K. Turteltaub,et al.  Methods of Dna Adduct Determination and Their Application to Testing Compounds for Genotoxicity , 2022 .

[14]  D Hoffmann,et al.  Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography-mass spectrometry. , 1999, Cancer letters.

[15]  A. Luch,et al.  Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites. , 1999, Carcinogenesis.

[16]  R. Santella.  Immunological methods for detection of carcinogen-DNA damage in humans. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  G. Mastrangelo,et al.  Influence of GSTM1 genotypes on anti-BPDE–DNA adduct levels in mononuclear white blood cells of humans exposed to PAH , 1999, International archives of occupational and environmental health.

[18]  R Fanelli,et al.  Seasonal effect on airborne pyrene, urinary 1-hydroxypyrene, and benzo(a)pyrene diol epoxide-hemoglobin adducts in the general population. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  S. Pavanello,et al.  HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans. , 1999, Carcinogenesis.

[20]  S. Hecht,et al.  Determination of Hemoglobin and Serum Albumin Adducts of Benzo[a]Pyrene by Gas Chromatography-Mass Spectrometry in Humans and Their Relation to Exposure and to other Biological Markers , 1999 .

[21]  R. Kozack,et al.  Molecular modeling of the major adduct of (+)-anti-B[a]PDE (N2-dG) in the eight conformations and the five DNA sequences most relevant to base substitution mutagenesis. , 1999, Carcinogenesis.

[22]  P. Dolara,et al.  Benzo[a]pyrene diol-epoxide DNA adducts and levels of polycyclic aromatic hydrocarbons in autoptic samples from human lungs. , 1998, Chemico-biological interactions.

[23]  G. Scherer,et al.  Determination of albumin adducts of (+)-anti-benzo[a]pyrene-diol-epoxide using an high-performance liquid chromatographic column switching technique for sample preparation and gas chromatography-mass spectrometry for the final detection. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[24]  E. Negri,et al.  Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  H. Bartsch,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. , 1998, Mutation research.

[26]  H. Bartsch,et al.  High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. , 1998, Pharmacogenetics.

[27]  S. Hecht,et al.  Gas chromatographic-mass spectrometric determination of benzo[a]pyrene and chrysene diol epoxide globin adducts in humans. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  N. Geacintov,et al.  The major, N2-dG adduct of (+)-anti-B[a]PDE shows a dramatically different mutagenic specificity (predominantly, G --> A) in a 5'-CGT-3' sequence context. , 1997, Biochemistry.

[29]  S. Tannenbaum,et al.  Identification of subdomain IB in human serum albumin as a major binding site for polycyclic aromatic hydrocarbon epoxides. , 1997, Chemical research in toxicology.

[30]  D. Patel,et al.  NMR solution structures of stereoisometric covalent polycyclic aromatic carcinogen-DNA adduct: principles, patterns, and diversity. , 1997, Chemical research in toxicology.

[31]  J. Angerer,et al.  Biological monitoring and biochemical effect monitoring of exposure to polycyclic aromatic hydrocarbons , 1997, International archives of occupational and environmental health.

[32]  R. Fanelli,et al.  Hemoglobin adducts of benzo[a]pyrene diolepoxide in newspaper vendors: association with traffic exhaust. , 1996, Carcinogenesis.

[33]  G. Grimmer,et al.  Trends in Environmental Pollution by PAH In Germany During the Period 1985–1995 , 1996 .

[34]  H. Bartsch,et al.  Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa. , 1996, Carcinogenesis.

[35]  P. S. Nielsen,et al.  Comparative synchronous fluorescence spectrophotometry and 32P-postlabeling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutations. , 1996, Mutation research.

[36]  D. Phillips.  DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke. , 1996, Environmental health perspectives.

[37]  H. Bartsch,et al.  Anti-benzo[a]pyrene diolepoxide--DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking. , 1995, Carcinogenesis.

[38]  J. Lewtas,et al.  Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  F. Kadlubar,et al.  Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. , 1995, Pharmacogenetics.

[40]  F. Perera,et al.  Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. , 1994, Carcinogenesis.

[41]  J. Zaia,et al.  Enantiospecificity of covalent adduct formation by benzo[a]pyrene anti-diol epoxide with human serum albumin. , 1994, Chemical research in toxicology.

[42]  J. Buchet,et al.  Determinants of benzo(a)pyrenediol epoxide adducts to haemoglobin in workers exposed to polycyclic aromatic hydrocarbons. , 1994, Occupational and environmental medicine.

[43]  H. Bartsch,et al.  Validation of a new fluorometric assay for benzo[a]pyrene diolepoxide-DNA adducts in human white blood cells: comparisons with 32P-postlabeling and ELISA. , 1994, Carcinogenesis.

[44]  D. Jerina,et al.  Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. , 1994, Drug metabolism reviews.

[45]  S. Tannenbaum,et al.  Protein adducts as biomarkers of human carcinogen exposure. , 1994, Drug metabolism reviews.

[46]  J. Buchet,et al.  Determinants of benzo[a]pyrene diol epoxide adducts to albumin in workers exposed to polycyclic aromatic hydrocarbons , 1994, International Archives of Occupational and Environmental Health.

[47]  E. Bowman,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. , 1993, Cancer research.

[48]  D. Phillips,et al.  DNA adducts in peripheral blood lymphocytes from aluminum production plant workers determined by 32P-postlabeling and enzyme-linked immunosorbent assay. , 1993, Environmental health perspectives.

[49]  G. Grimmer,et al.  Biomonitoring of polycyclic aromatic hydrocarbons in highly exposed coke plant workers by measurement of urinary phenanthrene and pyrene metabolites (phenols and dihydrodiols) , 1993, International archives of occupational and environmental health.

[50]  H. Bartsch,et al.  An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. , 1992, Cancer research.

[51]  N. van Zandwijk,et al.  Polycyclic aromatic hydrocarbon--DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. , 1992, Carcinogenesis.

[52]  J. Zaia,et al.  Benzo[a]pyrene anti-diol epoxide covalently modifies human serum albumin carboxylate side chains and imidazole side chain of histidine(146) , 1991 .

[53]  E. Bowman,et al.  Fluorescence detection of benzo[a]pyrene--DNA adducts in human lung. , 1991, Carcinogenesis.

[54]  Stephen Naylor,et al.  Conversion of a hemoglobin alpha chain aspartate(47) ester to N-(2,3-dihydroxypropyl)asparagine as a method for identification of the principal binding site for benzo[a]pyrene anti-diol epoxide. , 1991, Chemical research in toxicology.

[55]  P J Lioy,et al.  Analysis of human exposure to benzo(a)pyrene via inhalation and food ingestion in the Total Human Environmental Exposure Study (THEES). , 1991, Journal of exposure analysis and environmental epidemiology.

[56]  Stephen Naylor,et al.  Gas chromatographic-mass spectrometric analysis of diols and tetrols from reactions of polycyclic aromatic hydrocarbon epoxides with hemoglobin. , 1991, Journal of chromatography.

[57]  Stephen Naylor,et al.  Molecular dosimetry of polycyclic aromatic hydrocarbon epoxides and diol epoxides via hemoglobin adducts. , 1990, Cancer research.

[58]  C. Harris,et al.  Synchronous fluorescence spectroscopic, immunoaffinity chromatographic and 32P-postlabeling analysis of human placental DNA known to contain benzo[a]pyrene diol epoxide adducts. , 1990, Carcinogenesis.

[59]  Stephen Naylor,et al.  Benzo[a]pyrene diol epoxide adduct formation in mouse and human hemoglobin: physicochemical basis for dosimetry. , 1990, Chemical research in toxicology.

[60]  Stephen Naylor,et al.  Origin of tetrahydrotetrols derived from human hemoglobin adducts of benzo[a]pyrene. , 1989, Chemical research in toxicology.

[61]  C. Harris,et al.  Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. , 1989, Chemical research in toxicology.

[62]  P B Farmer,et al.  Fluorescence and mass spectral evidence for the formation of benzo[a]pyrene anti-diol-epoxide-DNA and -hemoglobin adducts in humans. , 1989, Carcinogenesis.

[63]  C. Harris,et al.  Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  E. Cavalieri,et al.  ONE-ELECTRON OXIDATION IN AROMATIC HYDROCARBON CARCINOGENESIS. , 1985 .

[65]  M. Anderson,et al.  Formation and persistence of benzo(a)pyrene metabolite-DNA adducts. , 1985, Environmental Health Perspectives.

[66]  C. Harris,et al.  Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[67]  C. Harris,et al.  An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adducts. , 1985, Carcinogenesis.

[68]  D. Phillips.  Fifty years of benzo(a)pyrene , 1983, Nature.

[69]  A. Conney,et al.  Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. , 1982, Cancer research.

[70]  D. Nebert,et al.  Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. , 1982, Pharmacological reviews.

[71]  H. Gelboin.  Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. , 1980, Physiological reviews.

[72]  R. L. Carter,et al.  IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[73]  Peter W. Jones,et al.  Polynuclear Aromatic Hydrocarbons , 1979 .